Navigation Links
Genomatica Produces Pure BDO From Natural Sugars
Date:6/2/2009

complete package," said Matt Tirrell, dean of engineering at the University of California, Santa Barbara, and a member of Genomatica's Engineering Advisory Council. "The integration of fermentation and purification processes is vital to chemical manufacturers and an important step in Genomatica's development."

The generation of purified BDO will allow Genomatica's bio-manufacturing process to compete against petroleum-based equivalents and offer a cost advantage to producers. Many chemical producers are facing unprecedented business challenges as the global economic slowdown depresses demand, and the credit crisis hampers their ability to finance large-scale projects. Fluctuating natural gas prices and possible changes in environmental and climate regulation have added to the uncertainty for petrochemical producers.

The Genomatica Technology Advantage

Genomatica researchers were able to delicately refine the design of the process because of the integrated components that the company has developed. Genomatica's technology portfolio consists of proprietary best-in-class computational modeling, "wet lab" microbe modification and specialized chemical process engineering. The unique combination of all three elements allows for the creation of breakthrough bioprocesses to produce chemicals through faster and more integrated product development.

With proprietary computational modeling, Genomatica's researchers examine all possible biological pathways to create target chemicals from various low-cost, renewable feedstocks. In this case, they also used modeling and simulation to examine the by-products produced in earlier versions of the BDO manufacturing process, and determined exactly how to eliminate those by-products. This channels more sugar to make BDO. Armed with the "blueprint," Genomatica researchers then updated the microorganisms using a range of different state-of-the-art gen
'/>"/>

SOURCE Genomatica
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. New Genomatica Chemical Process Targets Ailing Ethanol Assets
2. New small-scale generator produces alternating current by stretching zinc oxide wires
3. High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkins Lymphoma
4. PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
5. Pioneering IVF Technique Produces Region's First Pregnancy
6. New technique produces genetically identical stem cells
7. Novel Investigational Regimen Combining Radiation Enhancing Agent With Ibritumomab Tiuxetan (Zevalin(R)) Produces High Rate of Complete Responses in Patients With Rituximab-Refractory Follicular Non-Hodgkins Lymphoma
8. CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
9. Anthrax vaccine produces immunity with nanoparticles, not needles
10. Anthrax vaccine produces immunity with nanoparticles, not needles
11. Cancer Fighting Nutrition Supplement, Caplex, Offers Cancer Patients A New All-Natural Treatment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... Healthcare Conference in Miami, FL on ... David A. Ramsay , Chief Financial Officer, will provide a ... the "Investors" section of Halozyme,s corporate website at www.halozyme.com ... days following the event. To access the live webcast, please ...
(Date:3/3/2015)... LEXINGTON, Ky. (PRWEB) March 03, 2015 ... aligning their schedules for one event: the Alltech REBELation ... USA, from May 17-20. Now in its 31st year, ... people from 70 countries, and the opportunity to join ... week, March 7 at 11:59 p.m. EST, at which ...
(Date:3/3/2015)... , Mar. 03, 2015 Research and Markets ... the "Gene Therapy Market, 2015 - 2025" ... Therapy Market, 2015-2025" report provides an extensive study on ... research has been carried out in this field for ... therapies (four available in Asian markets; one approved in ...
(Date:3/3/2015)... Diagnostics Inc. (TSX:V: SQD), a life sciences company that ... advanced microarray diagnostics, today announced it has appointed ... team. In his capacity as CFO he will ... development stage to a commercially successful company including ... market strategy and to secure funding to drive ...
Breaking Biology Technology:Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3
... Inc. (Nasdaq: NVAX ) announced today the appointment ... Mr. Erck has more than twenty five years of experience ... as President and Chief Executive Officer of Iomai Corporation, a ... in 2008 by Intercell. Previously, Mr. Erck was President ...
... REYKJAVIK, Iceland, June 26 deCODE genetics,(Nasdaq: ... from the the Nasdaq,Hearing and Listing Review Council that the ... Nasdaq Global Market effective from the,opening of trading on Monday, ... symbol DCGN. , The reinstatement follows ...
... N.C., June 26 Syngenta Biotechnology, Inc. announced today ... Evogene, Ltd., focusing on identifying plant genes related to ... exclusive licensing rights to candidate genes discovered by Evogene ... is a soil parasite which attacks the roots of ...
Cached Biology Technology:Novavax Appoints Stanley Erck to Board of Directors 2Novavax Appoints Stanley Erck to Board of Directors 3deCODE Reinstated to Nasdaq Global Market 2deCODE Reinstated to Nasdaq Global Market 3Syngenta and Evogene to Collaborate on Soybean Nematode Resistance 2
(Date:2/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/sxwl43/global_2d_gesture ) ... 2D Gesture Recognition Market 2015-2019" report to ... the Global 2D Gesture Recognition market to grow ... 2014-2019 The increased demand for gesture-enabled ... the major trends in the market. The growing ...
(Date:2/13/2015)... Feb. 13, 2015 ACT Genomics Co., ... aims to transform cancer genomic information into precision ... company has raised US$ 8 million in the its ... Taipei, Taiwan , ACT Genomics ... With the aim to implement next generation sequencing ...
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34
... kidney disease (CKD) put them at a greater risk ... according to a new study released today in the ... Johns Hopkins University and the University of Maryland contributed ... of Kidney Disease and Hypertension (AASK) and the Chronic ...
... have long believed that microorganisms that produce methane swim toward ... has been too hard to prove in the lab. ... them to verify it for the first time, said Matthew ... co-author of a new paper describing the find. In ...
... 8, 2013 Research and ... addition of the "Europe Gesture Recognition ... Technology (2D, 3D, Ultrasonic, IR, Capacitive); Product ... (Germany, U.K., France, Italy, MEA)" report ...
Cached Biology News:Gene puts African-Americans at higher risk for kidney failure 2Montana State team overcomes challenges, proves that microbes swim to hydrogen gas 2Europe Gesture Recognition & Touchless Sensing Market (2013 - 2018) 2
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
... the premium quality siRNAs you need for ... be readily ordered online by providing either ... providing the sense and antisense siRNA sequences. ... Silencer Pre-designed siRNAs, which are already designed ...
... siRNA service provides the premium quality siRNAs ... Custom siRNAs can be readily ordered online ... sequence, or by providing the sense and ... Silencer Validated and Silencer ...
Human SDNSF/MCFD2 Biotinylated Affinity Purified PAb...
Biology Products: